跳至主要内容
临床试验/NL-OMON47289
NL-OMON47289已完成不适用

Graded Exposure in patients with Painful Diabetic Neuropathy - PDN & GEXP

Adelante Zorggroep0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age > 18 years
  • - Diabetes mellitus type II
  • - Clinical neurological examination, CNE > 5
  • - Diabetic Neuropathy Symptom Score, DNS >= 1
  • - Douleur Neuropathique 4 Questions, DN4 >= 3

排除标准

  • Patients with lower limb morbidities other than PDN such as peripheral arterial disease, severe osteoarthritis, any other neurological disease than PNP or any other disease that may cause pain in the feet and/or damage to the peripheral nervous system. Furthermore patients who have received any form of cognitive behavioural therapy in the last 6 months will be excluded.

研究者

发起方
Adelante Zorggroep

相似试验